Achieve Life Sciences, Inc. (ACHV): R&D Expense
$22.82M
Year ended 2024-12-31
-1.6%
3-year compound annual growth
+18.7%
5-year compound annual growth
-6.8%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $22.82M | +44.3% | 2025-03-11, From 2024-01-01 |
| 2023-12-31 | $15.81M | -47.4% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $30.08M | +25.5% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $23.97M | +248.2% | 2024-03-28, From 2021-01-01 |
| 2020-12-31 | $6.88M | -28.9% | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | $9.67M | +64.9% | 2022-03-10, From 2019-01-01 |
| 2018-12-31 | $5.87M | +89.2% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $3.10M | +984.3% | 2020-03-13, From 2017-01-01 |
| 2016-12-31 | $286.0K | -98.9% | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | $25.11M | -45.7% | 2017-02-23, From 2015-01-01 |
| 2014-12-31 | $46.22M | -16.4% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $55.32M | +38.5% | 2016-03-09, From 2013-01-01 |
| 2012-12-31 | $39.95M | +85.3% | 2015-03-26, From 2012-01-01 |
| 2011-12-31 | $21.55M | +16.6% | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | $18.48M | -8.5% | 2013-03-07, From 2010-01-01 |
| 2009-12-31 | $20.21M | n/a | 2012-03-08, From 2009-01-01 |